OBJECTIVE: To examine the impact of various flexible sick leave policies (FSLPs) on workplace attendance of employees with self-reported "severe" influenza-like-illness (ILI) symptoms. METHODS: This is a prospective study of employees from three US employers, which involved collection of information on employees' access to FSLPs and monthly experience with ILI and workplace attendance from November 2007 to April 2008. Multivariate analyses were used to estimate the impact of FSLPs on employees' workplace attendance while they were experiencing severe ILI symptoms. RESULTS: Among 793 employees with ILI, the average duration of severe ILI symptoms was 3.0 days. Most employees (71.9%) attended work with severe ILI symptoms, for an average of 1.3 days. Employees who could telework had a 29.7% lower rate of attending work with severe ILI symptoms (P = 0.026). CONCLUSIONS: Employers that implement teleworking policies may be able to reduce employee-to-employee transmission of respiratory illness, including seasonal and pandemic influenza.
OBJECTIVE: To examine the impact of various flexible sick leave policies (FSLPs) on workplace attendance of employees with self-reported "severe" influenza-like-illness (ILI) symptoms. METHODS: This is a prospective study of employees from three US employers, which involved collection of information on employees' access to FSLPs and monthly experience with ILI and workplace attendance from November 2007 to April 2008. Multivariate analyses were used to estimate the impact of FSLPs on employees' workplace attendance while they were experiencing severe ILI symptoms. RESULTS: Among 793 employees with ILI, the average duration of severe ILI symptoms was 3.0 days. Most employees (71.9%) attended work with severe ILI symptoms, for an average of 1.3 days. Employees who could telework had a 29.7% lower rate of attending work with severe ILI symptoms (P = 0.026). CONCLUSIONS: Employers that implement teleworking policies may be able to reduce employee-to-employee transmission of respiratory illness, including seasonal and pandemic influenza.
Authors: Hilary M Babcock; Susan E Beekmann; Satish K Pillai; Scott Santibanez; Leslie Lee; David T Kuhar; Angela P Campbell; Anita Patel; Philip M Polgreen Journal: Infect Control Hosp Epidemiol Date: 2019-11-14 Impact factor: 3.254
Authors: Faruque Ahmed; Sara Kim; Mary Patricia Nowalk; Jennifer P King; Jeffrey J VanWormer; Manjusha Gaglani; Richard K Zimmerman; Todd Bear; Michael L Jackson; Lisa A Jackson; Emily Martin; Caroline Cheng; Brendan Flannery; Jessie R Chung; Amra Uzicanin Journal: Emerg Infect Dis Date: 2020-01 Impact factor: 6.883
Authors: Sarah Daniels; Hua Wei; Yang Han; Heather Catt; David W Denning; Ian Hall; Martyn Regan; Arpana Verma; Carl A Whitfield; Martie van Tongeren Journal: BMC Public Health Date: 2021-10-28 Impact factor: 3.295